Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 306,626 | 213,979 | 206,440 | 149,992 | 605,872 |
| Cost of Goods | 65,237 | 48,545 | 47,413 | 36,263 | 32,685 |
| Gross Profit | 241,389 | 165,434 | 159,027 | 113,729 | 573,187 |
| Operating Expenses | 684,913 | 737,718 | 621,765 | 588,830 | 503,705 |
| Operating Income | -443,287 | -571,739 | -462,325 | -474,838 | 70,167 |
| Other Income | 22,038 | -15,065 | 29,247 | -5,733 | -8,302 |
| Pre-tax Income | -421,249 | -586,804 | -433,078 | -480,571 | 61,865 |
| Income Tax | 13,949 | 19,052 | 5,036 | -230 | -4,630 |
| Net Income Continuous | -435,198 | -605,856 | -438,114 | -480,341 | 66,495 |
| Net Income | $-435,198 | $-605,856 | $-438,114 | $-480,341 | $66,495 |
| EPS Basic Total Ops | -4.25 | -6.49 | -4.72 | -5.23 | 0.73 |
| EPS Basic Continuous Ops | -4.25 | -6.49 | -4.72 | -5.23 | 0.73 |
| EPS Diluted Total Ops | -4.25 | -6.45 | -4.72 | -5.23 | 0.69 |
| EPS Diluted Continuous Ops | -4.25 | -6.45 | -4.72 | -5.23 | 0.69 |
| EBITDA(a) | $-426,687 | $-558,618 | $-450,148 | $-463,311 | $79,799 |